$45.63
-2.08-4.37%
Last update: 11:56 AM
15 minutes delayed
Comments
Loading...
Janux Therapeutics
JANXNASDAQ
Janux Therapeutics (NASDAQ:JANX) Stock, Insider Trading Activity
Janux Therapeutics: Insider buying and selling updated today.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Janux Therapeutics Inc Insiders Doing?
Insiders have report no purchases/sales in the last 30 days.
Notable Recent Insider Buys and Sales
- On June 5, 2024, Tighe Reardon, the company's ACTING CHIEF FINANCIAL OFFICER sold 822.72K shares for $54.75 each.
- On June 5, 2024, Jay Lichter, the company's - sold 1.5M shares for $54.75 each.
- On June 5, 2024, Avalon Ventures XI LP, Avalon BioVentures I LP, Avalon BioVentures SPV I LP, the company's 10% OWNER sold 1.5M shares for $54.75 each.
Ownership Statistics for Janux Therapeutics Inc
Institutional Shares Held
16.871M
Institutional Percentage Held
32.5%
| Jun 05, 2024 | Jay Lichter | — | -1.50M | $54.75 | -$82.13M | SELL | -30.96% | 3.34M | Jun 03 | View |
| Jun 05, 2024 | Tighe Reardon | ACTING CHIEF FINANCIAL OFFICER | -822.72K | $54.75 | -$45.04M | SELL | -18.97% | 3.52M | Jun 03 | View |
| Jun 05, 2024 | Avalon Ventures XI LPAvalon BioVentures I LPAvalon BioVentures SPV I LP | 10% OWNER | -1.50M | $54.75 | -$82.13M | SELL | -30.99% | 3.34M | Jun 03 | View |
| Nov 15, 2023 | Tighe Reardon | ACTING CHIEF FINANCIAL OFFICER | 849.85K | $5.87 | $4.99M | BUY | 18.97% | 5.33M | Nov 13 | View |
| Nov 15, 2023 | Jay Lichter | DIRECTOR | 849.85K | $5.87 | $4.99M | BUY | 18.97% | 5.33M | Nov 13 | View |
| Nov 13, 2023 | Avalon Ventures XI LPAvalon BioVentures SPV I LPAvalon BioVentures I LP | 10% OWNER | 849.85K | $5.87 | $4.99M | BUY | 18.97% | 5.33M | Nov 13 | View |
| Jul 21, 2023 | RA CAPITAL MANAGEMENT LPRA Capital Healthcare Fund LPRA Capital Nexus Fund II LPPeter KolchinskyRajeev Shah | DIRECTOR | 495.01K | $12.46 | $6.17M | BUY | 5.71% | 9.17M | Jul 19 | View |
| Dec 30, 2021 | ORBIMED ADVISORS LLCOrbiMed Capital GP VIII LLCOrbiMed Genesis GP LLC | DIRECTOR | -40.40K | $20.30 | -$820.12K | SELL | -14.88% | 231.10K | Dec 29 | View |
| Dec 30, 2021 | Peter Thompson | DIRECTOR | -40.40K | $20.30 | -$820.12K | SELL | -14.88% | 231.10K | Dec 29 | View |
| Dec 23, 2021 | ORBIMED ADVISORS LLCOrbiMed Capital GP VIII LLCOrbiMed Genesis GP LLC | DIRECTOR | -119.40K | $19.00 | -$2.27M | SELL | -33.71% | 234.80K | Dec 21 | View |
| Dec 23, 2021 | Peter Thompson | DIRECTOR | -119.40K | $19.00 | -$2.27M | SELL | -33.71% | 234.80K | Dec 21 | View |
| Dec 17, 2021 | Peter Thompson | DIRECTOR | -393.30K | $19.07 | -$7.50M | SELL | -61.53% | 245.90K | Dec 16 | View |
| Dec 17, 2021 | ORBIMED ADVISORS LLCOrbiMed Capital GP VII LLCOrbiMed Genesis GP LLC | DIRECTOR | -393.30K | $19.07 | -$7.50M | SELL | -61.53% | 245.90K | Dec 16 | View |
| Jun 16, 2021 | Bregua Corp | 10% OWNER | 3.75M | $17.00 | $999.99K | BUY | ∞ | 3.75M | Jun 15 | View |
| Jun 16, 2021 | Peter Thompson | DIRECTOR | 3.04M | $17.00 | $12.00M | BUY | ∞ | 282.40K | Jun 15 | View |
| Jun 16, 2021 | ORBIMED ADVISORS LLCOrbiMed Capital GP VIII LLCOrbiMed Genesis GP LLC | DIRECTOR | 3.04M | $17.00 | $12.00M | BUY | ∞ | 282.40K | Jun 15 | View |
| Jun 16, 2021 | Tighe Reardon | ACTING CHIEF FINANCIAL OFFICER | 4.48M | $17.00 | $10.70M | BUY | 2590.27% | 4.65M | Jun 15 | View |
| Jun 16, 2021 | Jay Lichter | DIRECTOR | 8.67M | $17.00 | $10.70M | BUY | ∞ | 4.48M | Jun 15 | View |
| Jun 16, 2021 | Avalon Ventures XI LPAvalon BioVentures SPV I LP | 10% OWNER | 8.67M | $17.00 | $10.70M | BUY | ∞ | 4.48M | Jun 15 | View |
| Jun 16, 2021 | RA CAPITAL MANAGEMENT LPRA Capital Healthcare Fund LPPeter KolchinskyRajeev Shah | DIRECTOR | 8.67M | $17.00 | $50.00M | BUY | ∞ | 1.05M | Jun 15 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.